0001188112-13-001265.txt : 20130430 0001188112-13-001265.hdr.sgml : 20130430 20130430110933 ACCESSION NUMBER: 0001188112-13-001265 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20130429 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130430 DATE AS OF CHANGE: 20130430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREENWAY MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0001080747 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35413 FILM NUMBER: 13795242 BUSINESS ADDRESS: STREET 1: 1340 NORTH PARK STREET CITY: CARROLLTON STATE: GA ZIP: 30117 8-K/A 1 t76381_8ka.htm FORM 8-K/A t76381_8ka.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form 8-K/A
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  April 29, 2013
 
 
Greenway Medical Technologies, Inc.
(Exact name of registrant as specified in its charter)
 
 
Commission File Number: 001-35413

 
     
Delaware
  
58-2412516
(State or other jurisdiction
of incorporation)
  
(IRS Employer
Identification No.)
 
100 Greenway Boulevard
Carrollton, GA 30117
(Address of principal executive offices, including zip code)

(770) 836-3100
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
Explanatory Note

This amendment to the Current Report on Form 8−K filed by Greenway Medical Technologies, Inc. on April 29, 2013 (the “Original 8−K”) is being filed solely to correct a typographical error set forth in the press release furnished as Exhibit 99.1 to the Original 8-K. A corrected press release is furnished herewith as Exhibit 99.1. No other changes have been made to the Original 8−K.

Item 2.02.                      Results of Operations and Financial Condition

The following information is being furnished pursuant to Item 2.02 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

           On April 29, 2013, Greenway Medical Technologies, Inc. issued a press release announcing certain preliminary financial information for the quarter ended March 31, 2013 as well as updated guidance for its 2013 fiscal year, a copy of which is furnished herewith as Exhibit 99.1.

Item 7.01                      Regulation FD Disclosure.

The following information is being furnished pursuant to Item 7.01 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

The information contained in Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference to this Item 7.01.


Item 9.01.                      Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit is filed herewith.

Exhibit
No.
  
Description
99.1
  
Press Release dated April 29, 2013
 
 
 
 
 
 
SIGNATURE
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  Greenway Medical Technologies, Inc.  
       
       
Date:  April 30, 2013
By:
/s/ William G. Esslinger, Jr.  
    William G. Esslinger, Jr.  
   
Vice President, General Counsel and Secretary
  
EX-99.1 2 ex99-1.htm EXHIBIT 99.1 ex99-1.htm
EXHIBIT 99.1
 
GRAPHIC
 
 
NEWS RELEASE

 
CORRECTING and REPLACING Greenway Revises Fiscal 2013 Outlook
 
Expects Revenue of $132-$134 Million, Adjusted EBITDA of $5.8-$6.8 Million
 
CORRECTION...by Greenway Technologies
CARROLLTON, Ga.--(BUSINESS WIRE)--In the revised outlook for fiscal 2013 table, GAAP net income (loss) should be ($3.7) to ($3.2) [sted ($6.7) to ($5.7)].
 
 
The corrected release reads:
 
Greenway Revises Fiscal 2013 Outlook
 
Expects Revenue of $132-$134 Million, Adjusted EBITDA of $5.8-$6.8 Million
 
April 29, 2013, Carrollton, GA — Based on its preliminary results for the third quarter of fiscal 2013 as well as its estimates for the fiscal fourth quarter, Greenway Medical Technologies, Inc. (NYSE: GWAY), is revising its previously issued outlook for its 2013 fiscal year that will end June 30, 2013, to include expected revenue of $132 million to $134 million, and adjusted EBITDA of $5.8 million to $6.8 million. Greenway delivers innovative software and business service solutions for healthcare providers through its PrimeSUITE® platform.

Greenway’s preliminary results from operations for the fiscal third quarter, and anticipated activity for the fourth quarter, indicate an accelerated shift in revenue generated from the Company’s cloud-based subscription solutions including the fully integrated platform PrimeSUITE +S, the addition of cloud-based solutions that promote data liquidity, consumer engagement, and mobile accessibility to PrimeSUITE, as well as growth of the Company’s clinically driven revenue cycle management platform. This is offset by lower-than-anticipated one-time system sales as well as deferred training and consulting revenue at several large enterprise sites.

The following table summarizes the Company’s revised outlook for fiscal 2013 as of April 29, 2013:

 
Range
($ in millions except
per share data)
Revenue
$132.0 to $134.0
Gross profit
$68.0 to $70.0
Margin
51.5% to 52.2%
Operating income (loss)
($7.0) to ($6.0)
GAAP net income (loss)
($3.7) to ($3.2)
GAAP EPS
($0.13) to ($0.11)
Adjusted EBITDA
$5.8 to $6.8
Margin
4.4% to 5.1%
 
- more -
 
 
 
 
 
Greenway Revises Fiscal 2013 Outlook
April 29, 2013
Page 2 of 3
 
 
For the three months ended March 31, 2013, Greenway expects to report revenue from recurring sources of approximately 56 percent of total revenue, up from almost 46 percent for the prior-year period. Through nine months ended March 31, 2013, revenue from recurring sources is expected to be approximately 54 percent, up from almost 47 percent for the comparable prior-year period. The Company’s mix of revenue from recurring and non-recurring sources is also affected by lower system sales and deferred training and implementation.

“A key element to our long-term strategy is a deliberate shift to revenue from recurring sources, and these efforts are leading to adoption of our comprehensive PrimeSUITE platform through our cloud-based offerings at a rate that is greater than had been anticipated,” said Tee Green, president and chief executive officer of Greenway Medical Technologies, Inc. “This has had the impact of reducing system sales associated with one-time licenses, but generates a predictable recurring revenue stream. This interest in our cloud-based services is coming from all provider groups, including large enterprises. We continue to work with our new enterprise customers to deliver the Greenway experience, which includes award-winning training and services.”

During the three months ended March 31, 2013, Greenway added more than 425 providers to its PrimeSUITE platform, including more than 70 providers to its recently launched clinically driven revenue cycle management platform. There are more than 13,875 providers on Greenway’s PrimeSUITE platform as of March 31, 2013.

Greenway will report its third quarter results from operations on Monday, May 6, 2013, after the market closes, and will host an investor conference call that afternoon at 5 p.m. Eastern Daylight Time. The call can be accessed by dialing (866) 700-6067 or (617) 213-8834 for international calls. The participant code is 65582046. For listen-only mode, participants should go to the Investors section of www.greenwaymedical.com prior to the call to register and download the necessary audio software.
An audio replay will be posted following the call and will be available from approximately 7 p.m. Eastern time on May 6. The replay will be accessible through a link on www.greenwaymedical.com/investors.

Explanation of Non-GAAP Measures
 
The Company reports its financial results in accordance with U.S. GAAP. The Company’s management believes that investors may wish to consider the impact of certain non-cash or non-recurring items as a supplement to financial performance measures in accordance with GAAP. Management also presents results of operations before such items to evaluate operating performance, compare performance against past periods and as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate operating results and trends. Greenway’s non-GAAP adjusted EBITDA is defined as earnings before interest, taxes, depreciation and amortization, acquisition-related transaction costs and stock-based compensation.

About Greenway and PrimeSUITE
 
Greenway Medical Technologies, Inc. (NYSE: GWAY) delivers smarter solutions for smarter healthcare™. PrimeSUITE® — Greenway’s certified and fully integrated electronic health record, practice management and interoperability platform — helps improve care coordination, quality and cost-efficiency as part of a smarter, sustainable healthcare system. Thousands of care providers across primary care and more than 30 specialties and sub-specialties use cloud-based, remote-hosted or on-premise Greenway® solutions in healthcare enterprises, physician practices and clinics nationwide. For details, see greenwaymedical.com, Twitter, Facebook or YouTube.
 
 
 
 
 
Greenway Revises Fiscal 2013 Outlook
April 29, 2013
Page 3 of 3
 
 
Forward-Looking Statements
 
In addition to historical information, this press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the Company’s financial condition, growth strategy, business development efforts, service offerings, and service delivery models. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the Company’s future performance include, but are not limited to, our ability to adapt to evolving technology and industry standards; our ability to implement our growth strategy; our ability to retain management and other qualified personnel; failure to prevent disruptions in service or damage to our third-party providers’ data centers; failure to avoid liability for the use of content we provide; accelerated transition to a subscription pricing model, which would reduce our near-term revenues; regulation of the healthcare information technology industry; our ability to ensure our solutions meet industry and government standards; failure to maintain adequate security measures for our customers’ confidential information and personal identifiable information and their patients’ protected health information; our ability to obtain new provider customers; failure of the HITECH Act and other incentive programs to be fully implemented or funded by the government; our ability to implement our strategic relationships as currently intended; failure to establish, protect or enforce our intellectual property; restrictions in our credit facility and future indebtedness. Further information concerning these and other factors is included in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2012. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

Greenway, the Greenway logo and PrimeSUITE are registered trademarks and the phrase “smarter solutions for smarter healthcare” is a trademark of Greenway Medical Technologies, Inc. Other product or company names are the property of their respective owners.

###

Contact:
 
Bob Kneeley, Vice President, Investor Relations
(678) 390-7262
bobkneeley@greenwaymedical.com
 
  
 
 GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!`0$`'``<``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_ MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"``G`+`#`2(``A$!`Q$!_\0` M'@```04!`0$!`0````````````8'"`D*!0L#!`'_Q``X$``!!`(!!`(``P4& M!@,````#`0($!08'"``1$A,)%!4A(A87-GBU&",W=K>X"ADR.$-W)":T_\0` M'0$``00#`0$`````````````!0,$!@`8Y;9=F.3SF5M#CM'$).M+.8YCRJ*/'$BKXA`(TF2 M^%V6M$(LAF6GE*S&.-0!D3\ MW('QA2,%F*HH4A?5WI/FUVTLI%@AAUG'N@$AD\E5LN4;2&2O4 M1.[$1P8B/#V M^-*CO("3'>YBN#(`]X3#5I!ON)X>ZLBEXS,AD`++Z1RNHNIF%]J^6OZEQ?N1(:WO+&0A$PC$ M?=`2Q*>31"6/FK+R0NO(`D>KE)OS4\DI!G%BYCN"`UYF/^L.^XMGCB`CFJ4( M%D\*R2D=Q<9\Z+KG= MF$V.$92V$*TAQY1H4^ON*>08\>/<45U529M3A*\H[L"+/-&MQ579P)(P))%$09P.48W#-Q)7?B=IW_\ MW'DX2`Z!*V!MF5[`N":9^\'$X$\J/[HI$DT^I:U8INR]FE@MBO9V1S%:_P#4 MO/A?*MOV+[??ENZ++V>'C]W?-\/T^/GY>K\.QJ!W]GDGG[O;V];/7Z^[_-C. M+/`/D1S%HOQ\J>"/(#AM!PNQW968Q7QL^EWD+'G8]DT3('E/CP:P]DDID80UBM: M.WAJ%S^Z%5Q$3MZU[B7R_6@X)=5RVM;2:<5`5STZWY<4$:T**GWTJ/6*M=(K M`ESO9(C'[FP],6N]0#C1FWFU$V)"@C)R"T]+B9A6!]RZM$0;!$(/+S+\1\O3 MX2OE(WL28&9'R';RJDA32HD_DAM\D&4WNB^A`4EQCQ(@G=G(](AQ.\51`J%4 M\E_EA\HVZK/T_978(_1[/#\/Y3[\*W3"^QV];?7[_9ZN[_`%>' ML)YQWXK\+]XXM=) M0K&]E&B,3_$W735M[:'9SH; M'0HX1D:!P*B8I#^7B-S1M5/[Q%32#(=8+6#FU-`FJ+.GE6:6;-C'//BT2M*8 M9W:XU5ZZ+#-&8Y3S`612&^6_K$5G7G6B_*ALN/&``N&Y5.*(;!DF2N97/YDF2YJ=E,=L+E+#B M-(1?U/2-%CA157P$QO9$XK?D_P!Q"GOGQ1;%C?WYC!A.Y; MXWO8_8`!C_6'[[YANS&$*8IT]JQ+XU\9]I!'FO2;(80:G:2QC>L/BCB-5ZHOZ%15\/@UR'7E)$X>2\9K:O=5C^(D MK:^SN8T7'KXC:9NZT@Y$K'PI-9*H*><6'+$CFEEB=`(T4MAA"3@U%U6R5 M+'WJGU>Q0OY6'!XV[3PE40W,U-P$&+@M5L>HL9"7=.W5[CSR$[JA)).L>5UK M;KU;,'OI:UF]'C:EB#'P".QD)./;I1S151W;3[KPAY-(V^X!\^G[D_*5O:9* M"1]OL^MBC&]A8M%R1WR%TA[OS85\B^S/)',R*T0V,>SNBM1Z^Q.H_Y6=[ M_52*#(]QQE:)@AR6<@,NDRAH-&HCU+84TUIRN:WL\LIAWD5SGO5Q%\^J^-NZ MLRW2.R\RU/G8(,;,,$N3460`K9H[*"*P`,17MBSA-:.2+P,Q4*QJ(JJJ=ORZ MD[F/QX\E,(PW0&>6U+C$O'>3&2Z[Q+5,FER>+;$M+O:=4*YPR-8#BA M('(GT]]9\M')*I84<7.MO%:9[7O6SVG671$5J>*((MSK:>4#.W_4,+QLD^7CDC7273IVRM]3)3))"Q11=@:.;5@"1BM2.:LR'BOE(IJ#5S_62 M40G9/6Y6../WN9_9GQBQ,64;\NK[']>NKTQR/5RK M./<600H*G\8UQ$-&?);VE#9+<'R2'(\(I;VTGFW'7:F4Z;V,E,S-L-?4BO@4 M%J*[K8Q[FCK_P#.EY*>Q5_; MG<_J\$1&?CO%+V(3R57.4O\`8B\58K?%$'ZDA*XH2Y% MM.OLV(!D:8\W'7(8Y48K/L&FQ1<;<17VE8TC6LBE"%A2(9$08_K/@[Q=^/#D MQR_Q"_SK36/X]+QC',B=BDZRR/(XV/#->#K8-M)AP/M!(DQT.#9UQIBC=_\` M'^]%1Z?WK>HH['U]E.J,_P`SUEF]>E7E^!9+#G]B7D`C$>%)"\VJNH]6E6R%G,:DAQ][FM2Y--;CKV2N_(5YS MQ5RO$G>-]QQ)!\'U=/4_-GN4$94M,\V')DO(J]G:[T;(8)B?DUHS1:*C1R.1 M/-R$AJYKE5J$H;"`C'^U@!DLX.V<7L M)3@L<(RF""L1\AGBX#H_D,E9$C@=O]G%]G+^#`Q.\TM]&//DV5'E$2POJ\), MD9B4QD_'V"9,CGI[Y[H=P)5HS#'0@RAEFLY98AC[$@2O?9ULHK59Y`8XY6)BD;DB[D;"Y>% M\TUC>V=+65NYLRIY%I(KZ\J67"/`KB+'GSI`XZD^[#YR5,AT`#RM1SFU+Y3Q MC<5H/-[8S;4,)Y)\JYF8Z[PN;K/&MATW[YMB:KV=M?#\)S6DHH];@>QKK"37 MX:4639I$P>>"KJZ^^GBR;)9U5;/NI(J,L?\``),27B$P[^+L6_S'1_U.+UZ` M'$_^&-Q?S2\E_P#5W)NKUZ`ZUUEU%RV4IY+4N5I&BN/F66O?R5X31K.]F>"6 MOFK^2KH+"U!`TM6.O,DNP6\O=K&L*DBO%:MV1(@D: M66)XLC9N1*)5@$9>%(I%5W'(JQ0XF.:'^(&I/Y0^&G^V76'5@7P'MQ-W,7,? MQL<-V1#T;E1L++,<)'CL$RK"0W+:M"$1SK4F/GL.WH&\R4[+I5)+CE82-,AR)$24(T8Y1/YCH:DAT?U:74]BG]0@PFKK%Z:H"BO- M%%=E#]EG!1;$:L9:[,`JSI&25`Y"GJN63`ZW&8EK^ZCQV=FLR0`J&D1+,G+@ M6!42J"7B)\"14)(VW&C7#^(5AS1Y2\H8^[^5.V]3\BL'W3LEV+ZMH236&KM" M4TO%18-FN+?B,T*P<-E.S"/44CZ^0H944<:?Y2#SI(QM?[.V-@<.8 M>PB83GF7XC%GR1C%)G1L;R"QI@3)`A=Q#/)%":8HQJHV$>YK/THG5I0/G*YW M!J6UQ+;5]$:BR7!BVD:C0SNRJK64S8_=SO$#41J-J7RG) M;?,\GR/,,@.R5?97?6^2W]L)%I9''&CL''CL-,E&(P`!C"%KD&) MC6-:U"/4S/=/,U1Q3:2BS-C.MD\U?S^9R]2>G/?AORQ2T8[,ELA7I'!I?ER1N9"SD\A?@D@EM1VG1ZR2JV4R,3 MVHOFL\U=*L4NRLL2#X+MLVWJG2NXL-X`XCM?:^>:PO7-QFSUC'P6T_9^1F^4 M5.N*2TD8Q.R%:RP;5M+#A)(B,:6ODV11DKZ^6EB>(U:$_G&VSF.<O\FU M^_"*O4F)"J\3LI,P=C*V!3Y/+==_MH"4"."/'IY+F,J850,DXU78U-T.?-;8 M&E5E9#K;GR"\E=T4VEZ7+GG&DOV7HR8V\DEG%V,:HCM5UB@N5TD,DYD>K==X; M/8?+8^C!;HV+5C`2B?VT6V6AQN/BK2U\D6LS-6:I95YJ-6+R&\ MOX)258>,W+LUW'M)=**_C$MXM(XC;J35CP"T=81ZAP3QC-M#1$,.O<*3'(DM MPE8<3NQ&U;_(3=<;;JIU<[0&$#=W;,@Q>' M?F)/KX;X$9TY'C:BH]W9R]EZ.4W/SD1S%H<4QO=5IBT^LPVWG7 M=(S'\7AT!AS["&R!)=(-&*1T@:QV-1@W(B,=WH_E>H.E`R]JC"W-!X MK3X[R97&UIX3W<16G1WFRPO#VV4-]+%)!"-I`E*7O-O$W!3S-L'_``\/\?8VVE+#'8$S.H-/ M77[LAQZ-D#"1J.1.DP&Q1R2#2,]I;&2I7M[J1%8U>R,_-U.1OR:\IN4^M9.I M]M7&&3F!1X=!I)ZV%*0I8+FSHYGD:)KS/4@D;V(G9%5.W6R=0=*3= M',5H>P+,>?Q*:F9'FTQC\K7EDS&2%VJM',39JI;PQ$<:);L0XZVTA95$9$"F M3*ZHPDF@J6G)>\F3I+ERK28>K=B=[]M;$(KWY,A!/CR%0":6.K.S$@<"(QSD MQ\$?_?#)_P#2N?\`]6Q#K1)K(FC>9VSM9!Z\S;O+)VQ&3T7U"QFG,5BL1D*4UVHF:MY')1K#$Q MB9&QMG$7:3M*C-:IW:+N\3&.-HG.[._#@J?DK_[\.4'_`+/LO_PU_6EW@MC8 M>3_!;@%:SCC.31&UJW)+%7^I"UYM*MVEAF-@:PJ.4A#Q9.,M9]5_M9#L$.]6 MM%)"W(+MW:>6[NV7F6V,[/!DYAG=R:]R`];"'6P2V!QB$]T6")SAQA>`6(@F M.5$5%7O^?4MN./R6%LDD@KF/]SVJ!Z<=2],Z9ZB:PS^H*V5M:8U.,MRJ4H()+I:; M45+.XUI8);<$`*^S,,^UABBSRK&Q)#@9I/5V'P^JL]D\I#=FP^8%W>"O'&U@ ME\K7R50O&\\<8V[!CE`E.RR.%))##5]KJ1C_`#)=QKY$U#4G)I#DQR3&5"G$ MJ1L6!!WCK6B<]I/6Z1)D$_=5?Q&P"2$C`)X$&\8I#XN-SF7L%-JB,Z M1"O]P9V^G,_Q1SL?KK^948XCD:B-1S**!7#5$[_FW\W/7NY7CXW?)7RHXJ:[ ME:OU-D6,1\5E9);94@LCQ2!D,^-:W4:OC3UC39;VO;&(ZM%+;'(TK4EGEF57 M(=6-@K$LY$:UC7!&AL9<>P#9D;:#^^"=(%);*>VQ$=5^Z&25JI+&9R_88\C2 M*OFJ]8ZJ]5<5K[3.DZ%2O>@S:V3EM:V+%>".M=<2C21.*]94J#7(7G M[RDY+WF/WVP=CV%5(QJI/45D+`"S<'JU#*F.FR)4N!2SA"F6!GJ(3Y9U<1(\ M:.%J-:/]7PY$\ZM_Y+/&K^KUM(CR<:MXN.1Z[)4**E2CE+8W`#*Z MP_%8XXTJT4P$=*L(<64CAJQ['GM==5=`:FT+D=$XS&ZEK18F/2AT=:O/CY*@ MFP--<7<>7'UQ'+B3>Q\UUIV]_FC;NRQSN:X!7T2U)K33&7TW:T[3J9>):*83 MZ!/9:J\`DQE=:4[/5B"R439JR6#*?7<:]U3OWZ0>S]BY+MW8F:[0S(T21E>?Y+;Y9D1H$1D"$6WNY MA9TY\6$-7#B@<()8T MO6YWL3BGO=YK,R5,U;N6DJO"L,*1U!%)M%P]1RUK![&A:6EB\ONH,DW?F,2! M9<-#RLT:36>X99%@R$]B=86C"1A(.#@)Q/(P[^+L6_S'1_U.+UZ`'$_^&-Q? MS2\E_P#5W)NO/_P[^+L6_P`QT?\`4XO7H`<3_P"&-Q?S2\E_]79&2>:R,B9;$AE>5*^FEF[K;\I#/_``Z9I7UZ2HCU1%5HF*[ MQ8='01OTH]+W*EI=2?$[L%O8J(2;[;A^UA4V'C[1\-MSMMZ'-T2T:Q4F3+^# MN0MFD@;?\-PQRD#_`)"NV_C;QLG+;X4N2,+V,K<5VQF(5K+;),6W36P7R!1/>F+<79J M?:,PA&"0<'FO(.J.:$JH10M8B-_4K5B,?)?^(+5 M5R#]CLX/^Q!]-J+XRMN2''>.-E\,#3D''9;TVI@3C`;V4<@H*C?E[#`I$7LH M6V1W,+'(XB/5C7G1US;J7III?"&B:T-V4639,BV;CL!V?;\0O96`@'NMRW))V M78C8[U'F-(X?'&L84L/WC-R$TY(';[7$+VUC('[AWW)/@>1YWX]UQ,H:(Q(< M[;PPV"1_>*.7`K!1/\T?Z4))B7\QHAD>SQ>]HS$&WN[TO5$8[CWG&?`L;A-L M+KDUKB%#<=D9#?L-N:1W,1I'L9ZXFOSE3R:)Z^2L\$\>RN151%.CJJLE5Q=% M[@CQ-200,RIWK&4/\A/ENWD8MR1]_L/'@#SO"K4-.LTX6E`XC)"]R6Y^#^>% MI-]_S_XV]?@@:*T/,B+)DNHXU[$D";X- M>KU\^Z-5K7*TZ.@T-^A8EKPG3V(C!/!WCGS_`#DWV^3]S.2(&&QV[:(OR.ZG MX\626:TKQ1_2Z*?TLR29/D_V\MSR+J#X_H51Y/C[;*#^RSBPY+XI=X4\UWF) ML>328)E("[@G;^;D?/HU3Q]"T)>=54XE>)CELC;ER)_GF??;8 M`;_C[[GSZ5-+\<>RLDJ675%*OK*`7[#0$928!%>0X4NRYFUK M#C')E!$Q?`1RM>A?K,1"(,Z.KUT?T1T1G;6$BNKEE3)I7,_8R`C*&6+N,82U M>3CL?"]SN`+]P3Y]67@>G>G*Q7.&YC?:22%O-=JQ_457M:P!)CB":A/T$ M=Z&JPOPD[VC0V>G&=F7,]3N]BE+Q[QF&.*K/TJQ&\@,M,4Z$3LY'*$;F/[HK M'#\2G1U>0_27TK56`EU1R.^SG+5&9=SO\5;%F,[#XCDC';[[G<^K''0_18!' M]! MH]L:QNA@&1$8[R'+F.:QWDK4)Y`8JJ7X2L^F-8&TUCF]6848;C39?)/50XM\PQ$1Q#HZ(QSRM&"ZQ]Z254$DA50S$^I;I_1.&TU9DLXWO*\J%'5H\ 6?$A'X)%*C49RHY!.XSA>;[`%B?7_V3\_ ` end